Long-term treatment of endometriosis?

Child of a looser God. Fertil Steril (1997) 0.75

Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis. Fertil Steril (1995) 1.45

Gonadotropin-releasing hormone analogue (goserelin) plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial. Fertil Steril (1995) 1.41

Fertility and ageing. Hum Reprod Update (2005) 2.68

Inguinal endometriosis: pathogenetic and clinical implications. Obstet Gynecol (1991) 1.90

Endometriosis and pelvic pain: relation to disease stage and localization. Fertil Steril (1996) 1.61

Association between idiopathic premature ovarian failure and fragile X premutation. Hum Reprod (2000) 1.57

Paracervical anesthesia for outpatient hysteroscopy. Fertil Steril (1994) 1.51

Optimal use of infertility diagnostic tests and treatments. The ESHRE Capri Workshop Group. Hum Reprod (2000) 1.49

Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis. Am J Obstet Gynecol (1996) 1.46

Treatment with a gonadotrophin releasing hormone agonist before hysterectomy for leiomyomas: results of a multicentre, randomised controlled trial. Br J Obstet Gynaecol (1998) 1.43

GnRH agonists before surgery for uterine leiomyomas. A review. J Reprod Med (1996) 1.41

Fibroids and female reproduction: a critical analysis of the evidence. Hum Reprod Update (2007) 1.41

Laparoscopic ovarian puncture for correct staging of endometriosis. Fertil Steril (1990) 1.39

Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding. Obstet Gynecol (1997) 1.38

Association between endometriosis stage, lesion type, patient characteristics and severity of pelvic pain symptoms: a multivariate analysis of over 1000 patients. Hum Reprod (2006) 1.32

Uterine leiomyoma and menstrual cycle characteristics in a population-based cohort study. Hum Reprod (2004) 1.31

A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis. Fertil Steril (1993) 1.29

The European study of assisted reproduction families: family functioning and child development. Hum Reprod (1996) 1.25

Does laparoscopic excision of endometriotic ovarian cysts significantly affect ovarian reserve? Insights from IVF cycles. Hum Reprod (2003) 1.21

Progestins for symptomatic endometriosis: a critical analysis of the evidence. Fertil Steril (1997) 1.16

Seveso Women's Health Study: a study of the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on reproductive health. Chemosphere (2000) 1.15

Molecular definition of Xq common-deleted region in patients affected by premature ovarian failure. Hum Genet (2000) 1.14

Abdominal myomectomy for infertility: a comprehensive review. Hum Reprod (1998) 1.14

Endometrioma of the liver. Am J Obstet Gynecol (1990) 1.14

Guidelines for the diagnosis and treatment of hyperprolactinemia. J Reprod Med (1999) 1.13

Serum gonadotropin and steroid patterns during the normal menstrual cycle. Am J Obstet Gynecol (1971) 1.12

Risk factors for adenomyosis. Hum Reprod (1997) 1.12

Inheritance in idiopathic premature ovarian failure: analysis of 71 cases. Hum Reprod (1998) 1.10

Validation study of nonsurgical diagnosis of endometriosis. Fertil Steril (2001) 1.09

The role of transvaginal ultrasonography and outpatient diagnostic hysteroscopy in the evaluation of patients with menorrhagia. Hum Reprod (1997) 1.08

Efficacy of double intrauterine insemination in controlled ovarian hyperstimulation cycles. Fertil Steril (1999) 1.04

Is ureteral endometriosis an asymmetric disease? BJOG (2000) 1.03

Endometriosis and ovarian cancer. Am J Obstet Gynecol (1993) 1.02

Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. Am J Obstet Gynecol (1997) 1.00

Adenomyosis at hysterectomy: a study on frequency distribution and patient characteristics. Hum Reprod (1995) 1.00

The effect of surgery for symptomatic endometriosis: the other side of the story. Hum Reprod Update (2009) 0.99

Unexplained infertility: a review of diagnosis, prognosis, treatment efficacy and management. Int J Gynaecol Obstet (1992) 0.98

Mutation analysis of two candidate genes for premature ovarian failure, DACH2 and POF1B. Hum Reprod (2004) 0.98

Premature ovarian failure. Mol Cell Endocrinol (2000) 0.97

Transvaginal ultrasonography versus hysteroscopy in the diagnosis of uterine submucous myomas. Obstet Gynecol (1991) 0.96

Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulation syndrome. Hum Reprod (2005) 0.96

The idiopathic forms of premature menopause and early menopause show the same genetic pattern. Hum Reprod (1999) 0.93

Hysteroscopic myomectomy: long-term effects on menstrual pattern and fertility. Obstet Gynecol (1999) 0.93

Reproductive prognosis after hysteroscopic metroplasty in 102 women: life-table analysis. Fertil Steril (1993) 0.93

Spontaneous remission of Cushing syndrome after termination of pregnancy. Obstet Gynecol (1978) 0.93

Endocrine profile and therapeutic employment of a new prolactin-lowering drug, metergoline. Gynecol Obstet Invest (1980) 0.91

The distinguishing cellular and molecular features of the endometriotic ovarian cyst: from pathophysiology to the potential endometrioma-mediated damage to the ovary. Hum Reprod Update (2013) 0.90

Suppression of puerperal lactation by metergoline. Obstet Gynecol (1978) 0.89

Concentration of chorionic gonadotrophin and chorionic somatomammotrophin in maternal serum, amniotic fluid and cord blood serum at term. J Obstet Gynaecol Br Commonw (1972) 0.88

Mutation analysis of the inhibin alpha gene in a cohort of Italian women affected by ovarian failure. Hum Reprod (2002) 0.87

Functional characterization of hypothalamic hyperprolactinemia. J Clin Endocrinol Metab (1982) 0.87

Hormonal contraception without estrogens. Hum Reprod Update (2003) 0.87

High levels of women's satisfaction and compliance with transdermal contraception: results from a European multinational, 6-month study. Gynecol Endocrinol (2010) 0.87

Side of origin of ovarian cancer. BMJ (1992) 0.87

Treatment for infertility and risk of invasive epithelial ovarian cancer. Hum Reprod (1997) 0.86

Comparison of luteal phase profile in gonadotrophin stimulated cycles with or without a gonadotrophin-releasing hormone antagonist. Hum Reprod (2001) 0.86

Laparoscopy versus laparotomy in conservative surgical treatment for severe endometriosis. Fertil Steril (1996) 0.85

Repetitive conservative surgery for recurrence of endometriosis. Obstet Gynecol (1991) 0.85

Mutations in the coding region of the FOXL2 gene are not a major cause of idiopathic premature ovarian failure. Mol Hum Reprod (2004) 0.85

Bladder detrusor endometriosis: clinical and pathogenetic implications. J Urol (1996) 0.85

Progestagens in threatened abortion. Lancet (1980) 0.85

Deficient antiendometrium lymphocyte-mediated cytotoxicity in patients with endometriosis. Fertil Steril (1991) 0.85

Mild endometriosis and infertility: a critical review of epidemiologic data, diagnostic pitfalls, and classification limits. Obstet Gynecol Surv (1991) 0.84

Principles of phenomics in endometriosis. Hum Reprod Update (2012) 0.84

Gestational aspects of uterus didelphys. J Reprod Med (1988) 0.84

A gonadotrophin-releasing hormone agonist compared with expectant management after conservative surgery for symptomatic endometriosis. Br J Obstet Gynaecol (1999) 0.84

Site of origin of epithelial ovarian cancer: the endometriosis connection. BJOG (2000) 0.84

The sacrospinous vaginal vault suspension: Critical analysis of outcomes. Int Urogynecol J Pelvic Floor Dysfunct (1999) 0.83

Degree of endosalpingeal deciliation (by S.E.M.) in hydrosalpinx is not prognostic for post-surgical fertility. Acta Eur Fertil (1984) 0.83

Menstrual characteristics in women with and without endometriosis. Obstet Gynecol (1997) 0.82

Determinants of reproductive outcome after abdominal myomectomy for infertility. Fertil Steril (1999) 0.82

Oral contraceptive use and risk of endometriosis. Italian Endometriosis Study Group. Br J Obstet Gynaecol (1999) 0.82

Analysis of p53 and ras gene mutations in endometriosis. Gynecol Obstet Invest (1994) 0.82

GnRH antagonists and mild ovarian stimulation for intrauterine insemination: a randomized study comparing different gonadotrophin dosages. Hum Reprod (2004) 0.82

Is cystic ovarian endometriosis an asymmetric disease? Br J Obstet Gynaecol (1998) 0.82

Abnormal uterine bleeding associated with iron-deficiency anemia. Etiology and role of hysteroscopy. J Reprod Med (1993) 0.82

Asymmetry in distribution of diaphragmatic endometriotic lesions: evidence in favour of the menstrual reflux theory. Hum Reprod (2007) 0.81

Repair of the uterine cavity after hysteroscopic septal incision. Fertil Steril (1990) 0.81

Enhanced quality of capacitated spermatozoa from oligoasthenozoospermic men after incubation in test yolk medium. Andrologia (1994) 0.81

Presacral neurectomy for the treatment of pelvic pain associated with endometriosis: a controlled study. Am J Obstet Gynecol (1992) 0.81

Effect of central nervous system dopaminergic activation on prolactin secretion in man: evidence for a common central defect in hyperprolactinemic patients with and without radiological signs of pituitary tumors. J Clin Endocrinol Metab (1980) 0.81

Transvaginal ultrasonography versus uterine needle biopsy in the diagnosis of diffuse adenomyosis. Hum Reprod (1998) 0.80

Ultrasound in the diagnosis of subclasses of unicornuate uterus. Obstet Gynecol (1988) 0.80

Use of goserelin depot, a gonadotropin-releasing hormone agonist, for the treatment of menorrhagia and severe anemia in women with leiomyomata uteri. Acta Obstet Gynecol Scand (1990) 0.80

Lipoprotein(a) and other lipids after oophorectomy and estrogen replacement therapy. Obstet Gynecol (1996) 0.80

Surgical management of endometriosis. Baillieres Best Pract Res Clin Obstet Gynaecol (2000) 0.80

[Albumin, transferrin, IgA, IgG, IgM and beta-lipoprotein concentration in maternal serum, amniotic fluid and umbilical cord serum in normal pregnancy near term]. Gynecol Obstet (Paris) (1970) 0.80

A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study. Fertil Steril (1999) 0.80

Serum prolactin and ovarian function after discontinuation of drug treatment for hyperprolactinaemia: a study with bromocriptine and metergoline. Br J Obstet Gynaecol (1984) 0.80

A modified technique for correction of the complete septate uterus. Acta Obstet Gynecol Scand (1994) 0.80

Inhibition of prolactin release by serotonin antagonists in hyperprolactinemic subjects. Metabolism (1978) 0.80

Medical treatment of hyperprolactinaemic disorders. Hum Reprod (1986) 0.80

Treatment with GnRH agonists before myomectomy and the risk of short-term myoma recurrence. Br J Obstet Gynaecol (1990) 0.80

Individual patient data meta-analysis of randomized evidence to assess the effectiveness of laparoscopic uterosacral nerve ablation in chronic pelvic pain. Hum Reprod Update (2010) 0.80

Video display terminal use during pregnancy and reproductive outcome--a meta-analysis. J Epidemiol Community Health (1993) 0.79

Maternal and fetal platelet activation in normal pregnancy. Obstet Gynecol (1994) 0.79

Pregnancy after direct intraperitoneal insemination of spermatozoa from a man with severe infertility, after unsuccessful application of other methods of assisted fertilization. Hum Reprod (1990) 0.79

X chromosomes attached by their short arm : presence of an inactive centromere influences the replication patterns. Ann Genet (1980) 0.79

Very low dose danazol for relief of endometriosis-associated pelvic pain: a pilot study. Fertil Steril (1994) 0.79

Surgical measures for endometriosis-related infertility: a plea for research. Placenta (2011) 0.79